Value of covered stents to improve patency of long-segment SFA revascularization

U Beschorner1, T Zeller

  • 1Department of Angiology, University-Heart Center Freiburg-Bad Krozingen, Germany - ulrich.beschorner@herzzentrum.de.

Insights

Endovascular treatment for long femoropopliteal lesions shows promising results. The Viabahn endoprosthesis offers sustainable patency, potentially surpassing traditional surgical bypass methods.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Endovascular treatment is now a primary strategy for revascularizing complex femoropopliteal lesions.
  • There is a growing demand for endovascular techniques that ensure long-term patency.
  • Traditional surgical bypass procedures often utilize prosthetic materials.

Purpose of the Study:

  • To evaluate the efficacy and patency rates of the Viabahn endoprosthesis for femoropopliteal lesions.
  • To compare the performance of the Viabahn endoprosthesis against conventional surgical bypass.

Main Methods:

  • Review of recently published clinical trials.
  • Analysis of patency data for endovascular repair using the Viabahn endoprosthesis.
  • Comparison of outcomes with surgical bypass procedures.

Main Results:

  • The Viabahn endoprosthesis demonstrated promising patency rates in recent trials.
  • Patency rates achieved with the Viabahn endoprosthesis were comparable or superior to surgical bypass.
  • Viabahn endoprosthesis shows potential for sustainable success in complex lesion treatment.

Conclusions:

  • Endovascular treatment with the Viabahn endoprosthesis is a viable and effective option for femoropopliteal lesions.
  • The Viabahn endoprosthesis offers competitive or improved patency compared to surgical bypass.
  • Further research supports endovascular approaches for improved patient outcomes.